Searched for
PCSK9 INHIBITOR
Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...- Cardiologists share new guidelines on how to manage cholesterolUS cardiologists issue new guidelines for managing cholesterol. The updated US guidelines urge earlier identification and treatment of unhe...
- New cholesterol guidelines urge Americans to act earlier on ‘bad’ cholesterol and other blood fats to lower lifelong heart attack and stroke risk. Here's what you need to knowThe latest guidance from the US emphasizes the importance of identifying and treating abnormal blood fats earlier. This proactive strategy ...
- US FDA approves world's first oral cholesterol-lowering pill: What it means for patientsThe FDA has approved Lipfendra, an oral PCSK9 inhibitor, for high cholesterol. This new once-daily pill offers an alternative to injectable...
- Merck gets US FDA nod for first-in-its-class oral cholesterol drugThe U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- New daily pill could slash Cholesterol for patients who don’t respond to Statins, study findsA new pill called Enlicitide may help people who don’t get results from statins. The drug showed big drops in bad cholesterol in early test...
- Cholesterol test at age 18, Non-fasting measurement: Cardiologists Suggest New Guidelines on how to prevent heart attacksThe Cardiologist Society of India (CSI) now recommends lipid profiles starting at age 18, with non-fasting measurements as the new norm. Th...
Load More